| | |
| | Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 10 Days | |
| | Small Complex/Medium Specimen (Gallbladder, Appendix, cervical LLETZ cone, Tonsils, Adenoid, fibroid (cingle), excision breast (fibroadenoma, cyst), fallopian tube (with or without ectopic pregnancy), cervix, amputation, pilonidal sinus, Products of conception (POC), lipoma (large), breast reduction (Mammoplasty, specimen weight 150 gms and below), cyst (complex), lymph node, ovary (single), dermoid cyst, myoma, hemorrhoids, fistula, prostatic chips, fibroid (small). Sample Type : Fixed tissue in 10% Formalin
Methodology : Histopathology
TAT : 5 days | |
| | Sample Type : 24 Hour Urine
Methodology : Spectrophotometry
TAT : 10 Days | |
| | Sample Type : EDTA Plasma + Aprotinine
Methodology : Radioimmunoassay
TAT : 21 Days | |
| | Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 7 Days | |
| | Sample Type : Serum
Methodology : Chemiluminescence
TAT : 2 Days | |
| | Sample Type : Serum
Methodology : CLIA
TAT : 15 Days | |
| | Sample Type : Random Urine
Methodology : Immunochromatography
TAT : 1 Day | |
| | Sample Type : Whole Blood
Methodology : Real-time PCR
TAT : 2 Days | |
| | Sample Type : Swab/LBC/Urine
Methodology : PCR
TAT : 3 days | |
